PRIMARY STUDY
Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications
Key Findings: Dietary β-Caryophyllene may have therapeutic effects for use in treating insulin resistance, type 2 diabetes, obesity, hyperlipidemia, and diabetic complications.
Type of Study: Meta-analysis
Study Result: Positive
Study Location(s): United Arab Emirates
Year of Pub: 2020
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene
